Placebo-controlled study in neuromyelitis optica—Ethical and design considerations
Bruce Cree(University of California, San Francisco), Eliezer Katz, Dean M. Wingerchuk(WinnMed), Jeffrey L. Bennett(University of Colorado Denver), Gary Cutter(Epilepsy Foundation), Brian G. Weinshenker(Mayo Clinic in Arizona), Orhan Aktaş(Heinrich Heine University Düsseldorf), Jeffrey A. Cohen(Dartmouth Health), Friedemann Paul(Max Delbrück Center), Mark Sheehan(Wellcome Centre for Ethics and Humanities), Armando Flor, Kazuo Fujihara(Tohoku University), John N. Ratchford(Johns Hopkins University), Ho Jin Kim(National Cancer Center), Kaushik Patra, Hans-Peter Hartung(The University of Sydney), Soraya Madani, Sean J Pittock(Mayo Clinic), Gerard Barron
Cited by 72
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k